Lupin was up 0.43% at Rs 774.05 after the company announced the launch of Hydrocortisone Valerate cream in the US.
Lupin's Hydrocortisone Valerate Cream USP, 0.2%, is the generic equivalent of Westcort Cream, 0.2%, of Sun Pharmaceutical Industries Inc. It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses in adult patients.According to IQVIA MAT, Hydrocortisone Valerate Cream had an annual sales of $11.5 million in the US markets.
In a separate announcement today, Lupin announced the launch of "ADHERO," a new connec ted smart device for metered-dose inhalers. This first-of-its- kind device is designed to help pat ients with chronic respiratory diseases track their MDI usage and facilitate improved adherence to therapy.
Meanwhile, the NSE Nifty 50 index was trading 54.6 points lower at 11,913.80.
Lupin is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app